Ross D Crosby Selected Research

Bulimia (Binge Eating)

1/2022	Micro-level de-coupling of negative affect and binge eating in relationship to macro-level outcomes in binge eating disorder treatment.
7/2021	Examining prospective mediational relationships between momentary rumination, negative affect, and binge eating using ecological momentary assessment.
1/2021	Examination of momentary maintenance factors and eating disorder behaviors and cognitions using ecological momentary assessment.
1/2021	Dynamic Stress Responses and Real-Time Symptoms in Binge-Eating Disorder.
1/2020	Somatic symptoms and binge eating in women's daily lives.
1/2020	Comparing integrative cognitive-affective therapy and guided self-help cognitive-behavioral therapy to treat binge-eating disorder using standard and naturalistic momentary outcome measures: A randomized controlled trial.
1/2020	Examining intra-individual variability in food-related inhibitory control and negative affect as predictors of binge eating using ecological momentary assessment.
1/2019	Loss of Control Eating and Binge Eating in the 7 Years Following Bariatric Surgery.
1/2018	Associations among eating disorder behaviors and eating disorder quality of life in adult women with anorexia nervosa.
1/2017	Is laxative misuse associated with binge eating? Examination of laxative misuse among individuals seeking treatment for eating disorders.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ross D Crosby Research Topics

Disease

27	Feeding and Eating Disorders (Eating Disorder) 05/2022 - 12/2006
27	Bulimia (Binge Eating) 01/2022 - 05/2003
27	Weight Loss (Weight Reduction) 12/2021 - 08/2002
19	Obesity 12/2021 - 08/2002
17	Anorexia Nervosa 11/2022 - 12/2006
10	Cognitive Dysfunction 01/2016 - 07/2011
9	Morbid Obesity 01/2021 - 07/2009
9	Vomiting 06/2016 - 01/2010
8	Overweight 01/2021 - 08/2002
8	Binge-Eating Disorder (Binge Eating Disorder) 01/2021 - 12/2012
7	Bulimia Nervosa 01/2020 - 02/2007
5	Binge Drinking 01/2016 - 01/2014
4	Hyperphagia (Overeating) 03/2022 - 02/2013
3	Obstructive Sleep Apnea 09/2021 - 09/2011
3	Thinness 01/2016 - 01/2014
3	Body Weight (Weight, Body) 01/2015 - 10/2003
3	Dementia (Dementias) 01/2015 - 01/2014
3	Weight Gain 04/2009 - 10/2005
2	Alcoholism (Alcohol Abuse) 02/2022 - 09/2008
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022 - 01/2021
2	Pain (Aches) 12/2021 - 01/2020
2	Acromegaly 01/2021 - 08/2020
2	Body-Weight Trajectory 01/2021 - 01/2018
2	Inflammation (Inflammations) 07/2015 - 01/2015
2	Alzheimer Disease (Alzheimer's Disease) 11/2014 - 01/2014
2	Breast Neoplasms (Breast Cancer) 01/2012 - 03/2011
2	Sleep Apnea Syndromes (Sleep Apnea) 09/2011 - 01/2010
1	Narcolepsy 09/2021
1	Disorders of Excessive Somnolence (Hypersomnia) 09/2021
1	Injection Site Reaction 01/2021
1	Drug-Related Side Effects and Adverse Reactions 08/2020
1	Fatigue 01/2020
1	Chest Pain (Chest Pains) 01/2020
1	Dyspnea (Shortness of Breath) 01/2020
1	Urticaria (Hives) 01/2018
1	Angioedema 01/2018
1	Appendicitis 01/2018
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 07/2016
1	Anxiety Disorders (Anxiety Disorder) 08/2015
1	Lower Urinary Tract Symptoms 12/2014
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 12/2014
1	Stroke (Strokes) 11/2014
1	Diabetes Mellitus 09/2012
1	Neoplasm Metastasis (Metastasis) 03/2011

Drug/Important Bio-Agent (IBA)

7	LaxativesIBA 01/2017 - 01/2010
7	Pharmaceutical PreparationsIBA 01/2016 - 01/2003
4	SolutionsIBA 05/2022 - 12/2006
4	Olanzapine (Zyprexa)FDA Link 04/2009 - 10/2005
4	Antipsychotic Agents (Antipsychotics)IBA 04/2009 - 10/2005
3	Indicators and Reagents (Reagents)IBA 01/2018 - 02/2013
3	Risperidone (Risperdal Consta)FDA LinkGeneric 12/2008 - 10/2005
2	Biological ProductsIBA 01/2021 - 03/2015
2	Phentermine (Adipex-P)FDA LinkGeneric 05/2016 - 10/2003
2	DiureticsIBA 01/2015 - 01/2010
2	GhrelinIBA 01/2015 - 02/2008
1	solriamfetolIBA 09/2021
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2021
1	BESIBA 01/2021
1	A 7 (A-7)IBA 01/2021
1	LigandsIBA 01/2021
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2021
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 08/2020
1	Omalizumab (Xolair)FDA Link 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	antineoplaston A10 (A 10)IBA 10/2016
1	Inosine Triphosphate (ITP)IBA 07/2016
1	romiplostim FDA Link 07/2016
1	Topiramate (Topamax)FDA LinkGeneric 05/2016
1	Blood Glucose (Blood Sugar)IBA 01/2015
1	LeptinIBA 01/2015
1	Tamsulosin (Flomax)FDA LinkGeneric 12/2014
1	Solifenacin Succinate FDA Link 12/2014
1	Hormones (Hormone)IBA 03/2014
1	Growth Hormone (Somatotropin)IBA 01/2014
1	Anabolic Androgenic SteroidsIBA 01/2014
1	Fluoxetine (Prozac)FDA LinkGeneric 12/2012
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2012
1	AdiponectinIBA 01/2012
1	Biomarkers (Surrogate Marker)IBA 01/2012
1	Insulin (Novolin)FDA Link 09/2011
1	Hemoglobins (Hemoglobin)IBA 09/2011
1	Zoledronic Acid (Zometa)FDA Link 03/2011
1	Denosumab FDA Link 03/2011
1	Orlistat (Xenical)FDA Link 07/2010

Therapy/Procedure

38	Bariatric Surgery 01/2022 - 09/2008
18	Gastric Bypass (Roux-en-Y Gastric Bypass) 02/2022 - 08/2002
17	Therapeutics 01/2022 - 05/2008
13	MEA protocol 03/2022 - 02/2007
9	Diet Therapy (Therapy, Diet) 01/2018 - 10/2011
4	Gastrectomy 12/2016 - 05/2008
3	Ambulatory Care (Outpatient Care) 11/2022 - 01/2020
3	Aftercare (After-Treatment) 01/2019 - 04/2008
2	Injections 01/2021 - 08/2020
2	Operative Surgical Procedures 01/2019 - 09/2010
1	Combined Modality Therapy 11/2022
1	Subcutaneous Injections 01/2021
1	Appendectomy 01/2018
1	Glycemic Control 01/2015
1	Secondary Prevention 12/2012
1	Caloric Restriction 10/2011